Additive Therapy of Plasmodium berghei-Induced Experimental Cerebral Malaria via Dihydroartemisinin Combined with Rapamycin and Atorvastatin

Cerebral malaria (CM), caused by Plasmodium falciparum, is the primary cause of death from severe malaria. Even after immediate parenteral therapy with antimalarial drugs, the mortality rate remains 15 to 25%. Currently, no effective therapeutic agents are available for the radical treatment of CM....

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xiaonan, Cheng, Weijia, Zhu, Huiyin, Li, Yuting, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101104/
https://www.ncbi.nlm.nih.gov/pubmed/36946739
http://dx.doi.org/10.1128/spectrum.02317-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101104/
https://www.ncbi.nlm.nih.gov/pubmed/36946739
http://dx.doi.org/10.1128/spectrum.02317-22

Ejemplares similares